Impact of cardiac resynchronization therapy on hospitalizations in the resynchronization-defibrillation for ambulatory heart failure trial

11Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND - : This study reports the impact of cardiac resynchronization therapy (CRT) on hospitalizations in patients randomized to implantable cardioverter-defibrillator (ICD) or ICD-CRT in the Resynchronization- Defibrillation for Ambulatory Heart Failure Trial (RAFT). METHODS AND RESULTS - : Hospitalization rates and lengths of hospital stay were compared between the 2 groups. At the 18-month follow-up, the numbers of patients hospitalized for any cause were similar in the ICD (n=351, 38.8%) and ICD-CRT (n=331, 30.0%) groups. The number of patients hospitalized for heart failure was significantly lower in the ICD-CRT (n=101, 11.3%) compared with the ICD (n=141, 15.6%; P=0.003) group. The number of patients hospitalized for a device-related indication was similar in the ICD-CRT group (n=147, 16.4%) and ICD group (n=126, 13.9%; P=0.148). The total number of hospitalizations for any cause (n=1448 versus n=1553; P=0.042), any cardiovascular cause (n=667 versus n=790; P=0.017), and any heart failure cause (n=385 versus n=505; P<0.0001) was significantly lower in ICD-CRT group compared with the ICD group, whereas the number of hospitalizations for device-related causes was significantly higher in the ICD-CRT group compared with the ICD group (246 versus 159; P<0.001). Although the reduction in hospitalizations for heart failure in the CRT-ICD group was offset by an increased number of hospitalizations for device-related indications, the length of hospital stay for any cause was significantly shorter in the ICD-CRT group (8.83±13.30 days) compared with the ICD group (9.59±14.40 days; P=0.005). CONCLUSION - : ICD-CRT therapy significantly reduces hospitalizations and total days in hospital in patients with New York Heart Association class II/III heart failure compared with ICD therapy despite increased admissions for device-related indications. © 2014 American Heart Association, Inc.

Cite

CITATION STYLE

APA

Gillis, A. M., Kerr, C. R., Philippon, F., Newton, G., Talajic, M., Froeschl, M., … Tang, A. S. (2014). Impact of cardiac resynchronization therapy on hospitalizations in the resynchronization-defibrillation for ambulatory heart failure trial. Circulation, 129(20), 2021–2030. https://doi.org/10.1161/CIRCULATIONAHA.112.000417

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free